Invesaro

Stocks Comparison

HeartSciences vs Hyperion Defi: revenue, profit, margins and growth compared

HeartSciences brought in $4.3K of revenue in fiscal 2026, Hyperion Defi $813.5K in fiscal 2025. Revenue changed by -0.7% at HeartSciences and +1,318.8% at Hyperion Defi on the year before, so Hyperion Defi grew faster. HeartSciences kept -211,666.5% of its revenue as net profit, Hyperion Defi -5,570.6%.

Side by side, latest fiscal year

HSCSHYPD
Fiscal year endedFY2026 (April 30, 2026)FY2025 (December 31, 2025)
Revenue$4.3K$813.5K
Revenue growth-0.7%+1,318.8%
Net income-$9.1M-$45.3M
Net margin-211,666.5%-5,570.6%
Free cash flow-$7.4Mn/a
Free cash flow margin-172,036.6%n/a
Earnings per share (diluted)-$3.48-$9.40
Cash$1.7M$6.3M
Debtn/an/a
Price to earningsn/an/a
Market value$9.1M$40.2M
Dividend yieldn/an/a
Rank by revenue in sector#749 of 751 · Health care#660 of 751 · Health care

Over the years

Revenue
HSCS FY2023: $14.4KHSCS FY2023: $5.2KHSCS FY2024: $18.6KHSCS FY2025: $4.4KHSCS FY2026: $4.3KHYPD FY2020: $2MHYPD FY2021: $14MHYPD FY2023: $3.8KHYPD FY2024: $57.3KHYPD FY2025: $813.5KFY20FY21FY23FY24FY25FY26
HSCS $4.3KHYPD $813.5K
Net income
HSCS FY2023: -$4.8MHSCS FY2023: -$6.4MHSCS FY2024: -$6.6MHSCS FY2025: -$8.8MHSCS FY2026: -$9.1MHYPD FY2018: -$17.3MHYPD FY2019: -$21.2MHYPD FY2020: -$19.8MHYPD FY2021: -$12.8MHYPD FY2022: -$28MHYPD FY2023: -$27.3MHYPD FY2024: -$49.8MHYPD FY2025: -$45.3MFY18FY19FY20FY21FY22FY23FY24FY25FY26
HSCS -$9.1MHYPD -$45.3M
Net margin
HSCS FY2023: -33,592.6%HSCS FY2023: -123,384.3%HSCS FY2024: -35,511.9%HSCS FY2025: -201,499.5%HSCS FY2026: -211,666.5%HYPD FY2020: -988.5%HYPD FY2021: -91.3%HYPD FY2023: -719,859.9%HYPD FY2024: -86,888.6%HYPD FY2025: -5,570.6%FY20FY21FY23FY24FY25FY26
HSCS -211,666.5%HYPD -5,570.6%
Revenue growth
HSCS FY2023: -64.2%HSCS FY2024: +261.2%HSCS FY2025: -76.6%HSCS FY2026: -0.7%HYPD FY2021: +600.0%HYPD FY2024: +1,414.0%HYPD FY2025: +1,318.8%FY21FY23FY24FY25FY26
HSCS -0.7%HYPD +1,318.8%
Free cash flow
HSCS FY2023: -$3.6MHSCS FY2023: -$5.8MHSCS FY2024: -$6.1MHSCS FY2025: -$7.4MHSCS FY2026: -$7.4MHYPD FY2018: -$13.1MHYPD FY2019: -$19.1MHYPD FY2020: -$6.6MHYPD FY2021: -$22.1MHYPD FY2022: -$25.6MHYPD FY2023: -$26.7MHYPD FY2024: -$30.3MFY18FY19FY20FY21FY22FY23FY24FY25FY26
HSCS -$7.4MHYPD -$30.3M

Fiscal years as each company reports them; the two may end in different months.

Questions about HeartSciences and Hyperion Defi

Which is bigger by revenue, HeartSciences or Hyperion Defi?

Hyperion Defi is bigger by revenue: $813.5K in fiscal 2025, against $4.3K for HeartSciences in fiscal 2026.

Which keeps more of its revenue as profit, HeartSciences or Hyperion Defi?

HeartSciences had a net margin of -211,666.5% in fiscal 2026; Hyperion Defi had -5,570.6% in fiscal 2025.

Which grew revenue faster, HeartSciences or Hyperion Defi?

In their latest fiscal years revenue changed by -0.7% at HeartSciences and +1,318.8% at Hyperion Defi.

Where do these numbers come from?

From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.

More comparisons

Compare more companies